FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children

J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):474-84. doi: 10.1097/QAI.0000000000001000.

Abstract

Regulatory T cells (Tregs) are functionally suppressive CD4 T cells, critical for establishing peripheral tolerance and controlling inflammatory responses. Previous reports of Tregs during chronic HIV disease have conflicting results with higher or lower levels compared with controls. Identifying true Tregs with suppressive activity proves challenging during HIV infection, as traditional Treg markers, CD25 and FOXP3, may transiently upregulate expression as a result of immune activation (IA). Helios is an Ikaros family transcription factor that marks natural Tregs with suppressive activity and does not upregulate expression after activation. Coexpression of FOXP3 and Helios has been suggested as a highly specific marker of "bona fide" Tregs. We evaluated Treg subsets by FOXP3 coexpressed with either CD25 or Helios and their association with HIV disease progression in perinatally infected HIV-positive children. Identifying Tregs by FOXP3 coexpression with Helios rather than CD25 revealed markedly higher Treg frequencies, particularly in HIV+ children. Regardless of antiretroviral therapy, HIV-infected children had a selective expansion of memory FOXP3+Helios+ Tregs. The rise in memory Tregs correlated with declining HIV clinical status, indicated by falling CD4 percentages and CD4:CD8 ratios and increasing HIV plasma viremia and IA. In addition, untreated HIV+ children exhibited an imbalance between the levels of Tregs and activated T cells. Finally, memory Tregs expressed IA markers CD38 and Ki67 and exhaustion marker, PD-1, that tightly correlated with a similar phenotype in memory CD4 T cells. Overall, HIV-infected children had significant disruptions of memory Tregs that associated with advancing HIV disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • ADP-ribosyl Cyclase 1 / metabolism
  • Anti-HIV Agents / therapeutic use
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • Child
  • Disease Progression*
  • Flow Cytometry
  • Forkhead Transcription Factors / drug effects
  • Forkhead Transcription Factors / metabolism*
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / pathology*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / isolation & purification
  • Humans
  • Ikaros Transcription Factor / metabolism*
  • Immunologic Memory
  • Inflammation / metabolism
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Ki-67 Antigen / metabolism
  • Lymphocyte Activation* / drug effects
  • Phenotype
  • Programmed Cell Death 1 Receptor / metabolism
  • T-Lymphocytes, Regulatory / cytology
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism*

Substances

  • Anti-HIV Agents
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • IKZF2 protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Ki-67 Antigen
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Ikaros Transcription Factor
  • ADP-ribosyl Cyclase 1